These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32920962)

  • 1. Serum levels of soluble PD1 in pemphigus vulgaris: A useful marker for disease severity.
    Zeid OA; Rashed L; Khalifa S; Saleh MA; Ragab N
    J Cosmet Dermatol; 2021 Apr; 20(4):1298-1302. PubMed ID: 32920962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does interleukin-33 level correlate with the activity of Pemphigus vulgaris?: A case-control study.
    Bakr RM; Sayed DS; Abd-Elkader AS; Kamel AA; Badran AY
    Dermatol Ther; 2021 Jan; 34(1):e14605. PubMed ID: 33249704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between serum cardiac troponin I level and PDAI score in patients with pemphigus vulgaris.
    Aryanian Z; Shakoei S; Esmaeili N; Daneshpazhooh M; Khayyat A; Bazrafshan F; Hatami P
    Arch Dermatol Res; 2024 Jul; 316(7):466. PubMed ID: 38990351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The elevated level of osteopontin in patients with pemphigus vulgaris: A cytokine-like protein with a therapeutic potential.
    Ketabi Y; Nasiri S; Kheirodin M; Tavakolpour S; Mozafari N
    Dermatol Ther; 2019 Jul; 32(4):e12973. PubMed ID: 31136685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ODSS vs. ABSIS and PDAI oral parts in pemphigus vulgaris: inter-rater reliability and testing times.
    Shamabadi A; Yazdinezhad S; Sadeghi Y; Moradi AR; Yazdchi A; Teymourpour A; Faramarzi A; Seirafi R; Balighi K; Mahmoudi H; Daneshpazhooh M
    Oral Dis; 2023 Oct; 29(7):2696-2704. PubMed ID: 35852132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Serum Levels of Interleukin-4 and Interleukin-21 in New Pemphigus Vulgaris Patients, but Not Chronic Patients With Inactive Disease Compared to Healthy Controls.
    Shahbazian P; Izad M; Daneshpazhooh M; Mortazavi H; Salehi Z; Behruzifar S; Tavakolpour S; Azizpour A
    Dermatol Pract Concept; 2021 Mar; 11(2):e2021035. PubMed ID: 33954018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the commitment index of skin and mucous membranes in pemphigus vulgaris for the clinical evaluation of patients with pemphigus vulgaris.
    Souza SR; Azulay-Abulafia L; Nascimento LV
    An Bras Dermatol; 2011; 86(2):284-91. PubMed ID: 21603812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and tissue levels of coenzyme Q10 in pemphigus vulgaris.
    Abdelkader HA; Rashed LA; Assaad E; Saleh MA
    J Cosmet Dermatol; 2022 Jul; 21(7):3002-3006. PubMed ID: 34601804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Ear, Nose, and Throat Involvement in Pemphigus Vulgaris in Comparison with Pemphigus Severity Scoring Systems: A Cross-sectional Study.
    Bilgic-Teme A; Cem Temel I; Bostancı-Toptas A; Turhan M; Bozkurt S; Uzun S
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):283-288. PubMed ID: 30665476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased oxidative stress in pemphigus vulgaris is related to disease activity and HLA-association.
    Shah AA; Dey-Rao R; Seiffert-Sinha K; Sinha AA
    Autoimmunity; 2016 Jun; 49(4):248-57. PubMed ID: 26911801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grading criteria for disease severity by pemphigus disease area index.
    Shimizu T; Takebayashi T; Sato Y; Niizeki H; Aoyama Y; Kitajima Y; Iwatsuki K; Hashimoto T; Yamagami J; Werth VP; Amagai M; Tanikawa A
    J Dermatol; 2014 Nov; 41(11):969-73. PubMed ID: 25346300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemphigus disease activity measurements: pemphigus disease area index, autoimmune bullous skin disorder intensity score, and pemphigus vulgaris activity score.
    Rahbar Z; Daneshpazhooh M; Mirshams-Shahshahani M; Esmaili N; Heidari K; Aghazadeh N; Hejazi P; Ghajarzadeh M; Chams-Davatchi C
    JAMA Dermatol; 2014 Mar; 150(3):266-72. PubMed ID: 24429657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. There might be a role for CD200 in the pathogenesis of autoimmune and inflammatory skin disorders.
    Akman-Karakaş A; Yalcin AD; Koç S; Gumuslu S; Senol YY; Özkesici B; Genc GE; Ergun E; Ongut G; Yilmaz E; Uzun S; Alpsoy E
    Med Sci Monit; 2013 Oct; 19():888-91. PubMed ID: 24157657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
    Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Oral Disease Severity Score validated for use in oral pemphigus vulgaris.
    Ormond M; McParland H; Donaldson ANA; Andiappan M; Cook RJ; Escudier M; Hullah E; Higham J; McMillan R; Taylor J; Shirlaw PJ; Challacombe SJ; Setterfield JF
    Br J Dermatol; 2018 Oct; 179(4):872-881. PubMed ID: 29297927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of tissue E-cadherin and its proteolytic serum fragment in pemphigus vulgaris before and after remission: A case-control study.
    Youssef RM; Saleh MA; Korany MM; Nour ZA; El-Kalioby M
    J Cosmet Dermatol; 2022 Nov; 21(11):6343-6350. PubMed ID: 35912419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool.
    Lenz P; Amagai M; Volc-Platzer B; Stingl G; Kirnbauer R
    Arch Dermatol; 1999 Feb; 135(2):143-8. PubMed ID: 10052398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mean Platelet Volume in Pemphigus Vulgaris.
    Kridin K; Shihade W; Zelber-Sagi S
    Angiology; 2018 Apr; 69(4):303-307. PubMed ID: 28681645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.